Search

49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year mortali

2-Year OUTCOMES from the triluminate pivotal trial New TriClip™ Transcatheter Edge-to-Edge Repair clinical data release   EXPLORE NOW INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TE

Therapies Valvular Diseases Mitral Valve Disease Aortic Valve Disease Tricuspid Valvle Disease Paravalvular Leak

ON DEMAND - TAVI SUMMIT 2025 3rd Abbott Annual Transcatheter Aortic Valve Implantation Summit SESSION 1: BEYOND THE TAVI IMPLANT: A STRATEGIC APPROACH TO LIFETIME MANAGEMENT SESSION 2: OPTIMIZING

ABBOTT CARDIAC SURGERY WEBINARS 2025 Don’t miss to watch on demand our Aortic and Mitral Valve Replacement Webinar Series, where experts discussed the latest advancements in valvular heart disease

ON DEMAND Imaging Webinars 2025 Echo guidance for screening and interventions in structural heart diseases PART 1: ANATOMICAL OVERVIEW IMAGING COURSES PART 2: MITRAL-TEER IMAGING COURSES PART 3

Watch R. S. von Bardeleben & E. Donal giving their perspective. R. S. von Bardeleben E. Donal RESHAPE-HF2 A second randomised clinical trial for MitraClip™ Transcatheter Edge-to-Edge Repai

SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion

SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion

LEARN MORE: AMPLATZER™ TALISMAN™ PFO OCCLUDER Clinical data Diagnosis  Prevention PFO CLOSURE: BEHIND THE NUMBERS Ischemic strokes are of unknown cause5 Of patients with an isch